NCT01368471已完成4 期
MASTER: MGUARD for Acute ST Elevation Reperfusion
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- InspireMD
- 入组人数
- 433
- 试验地点
- 7
- 主要终点
- The incidence of complete ST segment resolution (defined as ≥70% ST 1. The incidence of complete ST segment resolution
研究概览
简要总结
The goal of this study is to demonstrate the superiority of the MGuard™ stent over commercially-approved bare-metal (BMS) /drug-eluting stents (DES) in achieving better myocardial reperfusion in primary angioplasty for the treatment of acute ST-elevation myocardial infarction (STEMI).
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Participant)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
The incidence of complete ST segment resolution (defined as ≥70% ST 1. The incidence of complete ST segment resolution
时间窗: 60 to 90 minutes after the last angiogram
次要结局
- Major Adverse Cardiac Events (MACE)at discharge, 30 days, 6 months and 12 months post-procedure(discharge, 30 days, 6 and 12 months post-procedure)
- The incidence of Thrombolysis In Myocardial Infarction (TIMI) 3 flow at the end of the procedure.(60-90 minutes after last angiogram)
研究者
研究点 (7)
Loading locations...
相似试验
终止
不适用
MGuard™ Prime Stent System Clinical Trial in Patients With Acute ST Elevation Myocardial InfarctionST Elevation Myocardial InfarctionNCT01869738InspireMD310
已完成
不适用
MGuard Stent in ST-elevation Myocardial InfarctionST-elevation Myocardial InfarctionThrombusStentsNCT01124942Federico II University350
已完成
不适用
Gravity Stent-Retriever System For Reperfusion Of Large Vessel Occlusion Stroke TrialIschemic StrokeCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesStrokeNCT06249776Gravity Medical Technology, INC55
Unknown
不适用
Revascularization Strategies for STEMI; The CMR Endpoint StudyAcute Myocardial InfarctionNCT01818960Unity Health Toronto250
已完成
3 期
A Clinical Investigation of SM-01 Stenting Versus PTA for the Treatment of Superficial Femoral Artery DiseasePeripheral Vascular DiseasesNCT01183117Johnson & Johnson K.K. Medical Company105